Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
COMPASS Pathways plc CMPS
$8.23
-$0.28 (-3.46%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
375445828.00000000
-
week52high
21.50
-
week52low
6.54
-
Revenue
0
-
P/E TTM
-4
-
Beta
2.51163600
-
EPS
-2.15000000
-
Last Dividend
0.00000000
-
Next Earnings Date
28 февр 2023 г. в 13:00
Описание компании
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Citigroup | Buy | Buy | 05 авг 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 22 ноя 2021 г. |
| Oppenheimer | Outperform | 29 окт 2021 г. | |
| Citigroup | Buy | 13 июл 2021 г. | |
| Maxim Group | Buy | 28 июн 2021 г. | |
| Loop Capital | Buy | 01 ноя 2022 г. | |
| EF Hutton | Buy | 16 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Nath Kabir | A | 153900 | 153900 | 02 февр 2023 г. |
| Nath Kabir | A | 75200 | 25200 | 02 февр 2023 г. |
| Goldsmith George Jay | A | 67500 | 67500 | 02 февр 2023 г. |
| Goldsmith George Jay | A | 4272019 | 11700 | 02 февр 2023 г. |
| OWENS MATTHEW A | A | 63900 | 63900 | 02 февр 2023 г. |
| OWENS MATTHEW A | A | 21507 | 10800 | 02 февр 2023 г. |
| FALVEY MICHAEL | A | 45000 | 45000 | 02 февр 2023 г. |
| FALVEY MICHAEL | A | 22500 | 22500 | 02 февр 2023 г. |
| Malievskaia Ekaterina | A | 67500 | 67500 | 02 февр 2023 г. |
| Malievskaia Ekaterina | A | 4272019 | 11700 | 02 февр 2023 г. |
Новостная лента
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
The Motley Fool
07 февр 2023 г. в 05:52
These stocks are risky. But they just might deliver huge gains if analysts are right.
7 Tempting Sin Stocks to Buy for Promising Profits
InvestorPlace
06 февр 2023 г. в 20:28
Following a rough year, investors seeking positive returns might want to consider going a bit controversial with sin stocks. Understandably, with the political winds turning progressive, people nowadays turn a stink eye toward cynicism.
The 7 Most Promising Psychedelic Stocks to Buy in February
InvestorPlace
05 февр 2023 г. в 14:30
Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several pharmaceutical companies are now investigating their potential therapeutic value.
Psychedelic Sunday: Competitive Strategies
Seeking Alpha
15 янв 2023 г. в 11:45
Stephen Tobin on investing in psychedelic stocks while they're still pre-revenue. Will first-movers get the advantage?
All You Need to Know About COMPASS Pathways PLC Sponsored ADR (CMPS) Rating Upgrade to Strong Buy
Zacks Investment Research
13 янв 2023 г. в 13:33
COMPASS Pathways PLC Sponsored ADR (CMPS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).